{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:51:23Z","timestamp":1774673483602,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jtct.2021.11.017","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:51:07Z","timestamp":1638615067000},"page":"167.e1-167.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-5009","authenticated-orcid":false,"given":"Julia C.","family":"Gardner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Courter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-9203","authenticated-orcid":false,"given":"Christopher E.","family":"Dandoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Teusink-Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.11.017_bib0001","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4067\/S0716-97602012000300012","article-title":"Hematopoietic stem cell transplantation: clinical use and perspectives","volume":"45","author":"Barriga","year":"2012","journal-title":"Biol Res"},{"key":"10.1016\/j.jtct.2021.11.017_bib0002","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.11.017_bib0003","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/bmt.2008.66","article-title":"Bacteremias in children receiving hemopoietic SCT","volume":"41(suppl 2)","author":"Castagnola","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.017_bib0004","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbmt.2016.06.002","article-title":"Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation","volume":"22","author":"Dandoy","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.017_bib0005","article-title":"Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis","author":"Dandoy","year":"2017521091","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.017_bib0006","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.bbmt.2016.06.012","article-title":"Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation","volume":"22","author":"Ballen","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.017_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18668","article-title":"Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury\u2014laboratory-confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant","volume":"3","author":"Dandoy","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtct.2021.11.017_bib0008","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/ciz1082","article-title":"Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation","volume":"71","author":"Lehrnbecher","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2021.11.017_bib0009","unstructured":"Lexi-Comp, Inc. Levofloxacin. Available at: http:\/\/www.crlonline.com\/lco\/action\/doc\/retrieve\/docid\/chicin_f\/2937906?cesid=auRpo5aCLUz&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dlevofloxacin%26t%3Dname%26va%3Dlevofloxacin. Accessed November 11, 2021."},{"key":"10.1016\/j.jtct.2021.11.017_bib0010","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2706","article-title":"The use of systemic and topical fluoroquinolones","volume":"138","author":"Jackson","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtct.2021.11.017_bib0011","unstructured":"Centers for Disease Control and Prevention (CDC). Antimicrobial-resistant phenotype definitions: analysis of antimicrobial-resistant organisms in NHSN. Updated 06\/2021. Available at: https:\/\/www.cdc.gov\/nhsn\/pdfs\/ps-analysis-resources\/phenotype_definitions.pdf. Accessed March 4, 2021."},{"key":"10.1016\/j.jtct.2021.11.017_bib0012","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bbmt.2018.11.023","article-title":"Fluoroquinolone prophylaxis is highly effective for the prevention of central line\u2013associated bloodstream infections in autologous stem cell transplant patients","volume":"25","author":"Ziegler","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.017_bib0013","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.11.017_bib0014","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bbmt.2020.05.011","article-title":"The impact of antibiotic-mediated modification of the intestinal microbiome on outcomes of allogeneic hematopoietic cell transplantation: systematic review and meta-analysis","volume":"26","author":"Gavriilaki","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.017_bib0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11899-013-0193-y","article-title":"Gea-Banacloche J. Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation","volume":"9","author":"Callejas-D\u00edaz","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.jtct.2021.11.017_bib0016","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ajic.2019.11.025","article-title":"Evaluation of patient risk factors for infection with carbapenem-resistant Enterobacteriaceae","volume":"48","author":"Predic","year":"2020","journal-title":"Am J Infect Control"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721014044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721014044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:02:45Z","timestamp":1763002965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721014044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2666636721014044"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.11.017","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}